Benzothiazoles having histamine H3 receptor activity
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 12, 2013
Grant Date -
Nov 25, 2010
app pub date -
Mar 22, 2007
filing date -
Mar 28, 2006
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Certain novel benzothiazoles and benzoxazoles, e.g., 2-(piperazin-1-yl)benzothiazoles and 2-(piperazin-1-yl)benzoxazoles, optionally substituted in the 3 and/or 4 positions of the piperazine rings,! of the general formula (1): having histamine H3 antagonistic activity can be used in pharmaceutical compositions.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully